Terms: = Bone cancer AND DDIT3, CHOP, 1649, ENSG00000175197, _C/EBP zeta_, MGC4154, GADD153, CHOP10, P35638 AND Prognosis
103 results:
1. Role of plasma EBV-DNA load and EBER status on newly diagnosed peripheral T-cell lymphoma.
Chen J; Zhou J; Cheng F; Chen D; Guan F; Zhang E; He J; Cai Z; Zhao Y
J Cancer Res Clin Oncol; 2024 Apr; 150(4):181. PubMed ID: 38587664
[TBL] [Abstract] [Full Text] [Related]
2. Expression of the chemokine receptor CCR1 decreases sensitivity to bortezomib in multiple myeloma cell lines.
Zeissig MN; Hewett DR; Mrozik KM; Panagopoulos V; Wallington-Gates CT; Spencer A; Dold SM; Engelhardt M; Vandyke K; Zannettino ACW
Leuk Res; 2024 Apr; 139():107469. PubMed ID: 38479337
[TBL] [Abstract] [Full Text] [Related]
3. C/ebpα-p30 confers AML cell susceptibility to the terminal unfolded protein response and resistance to Venetoclax by activating ddit3 transcription.
Du M; Wang M; Liu M; Fu S; Lin Y; Huo Y; Yu J; Yu X; Wang C; Xiao H; Wang L
J Exp Clin Cancer Res; 2024 Mar; 43(1):79. PubMed ID: 38475919
[TBL] [Abstract] [Full Text] [Related]
4. Primary thyroid lymphoma: a case series.
Sakhri S; Zemni I; Ayadi MA; Kamoun S; Chargui R; Ben Dhiab T
J Med Case Rep; 2024 Feb; 18(1):108. PubMed ID: 38395921
[TBL] [Abstract] [Full Text] [Related]
5. Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes.
Noerenberg D; Briest F; Hennch C; Yoshida K; Hablesreiter R; Takeuchi Y; Ueno H; Staiger AM; Ziepert M; Asmar F; Locher BN; Toth E; Weber T; Amini RM; Klapper W; Bouzani M; Poeschel V; Rosenwald A; Held G; Campo E; Ishaque N; Stamatopoulos K; Kanellis G; Anagnostopoulos I; Bullinger L; Goldschmidt N; Zinzani PL; Bödör C; Rosenquist R; Vassilakopoulos TP; Ott G; Ogawa S; Damm F
J Clin Oncol; 2024 Feb; 42(4):452-466. PubMed ID: 38055913
[TBL] [Abstract] [Full Text] [Related]
6. High-intensity chemotherapy improved the prognosis of patients with high-grade B-cell lymphoma.
Chen Y; Cai Q; Chang Y; Zhang M; Li Z
Front Immunol; 2022; 13():1047115. PubMed ID: 36618391
[TBL] [Abstract] [Full Text] [Related]
7. Clinical characteristics and prognosis of patients with co-existing follicular lymphoma and diffuse large B-cell lymphoma components in rituximab era.
Chen Y; Luo L; Chen L; Zheng X; Yang X; Zheng Z; Zheng J; Liu T; Yang T; Hu J
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2311-2318. PubMed ID: 36219261
[TBL] [Abstract] [Full Text] [Related]
8. Intravascular Large B-Cell Lymphoma: A Review with a Focus on the Prognostic Value of Skin Involvement.
Breakell T; Waibel H; Schliep S; Ferstl B; Erdmann M; Berking C; Heppt MV
Curr Oncol; 2022 Apr; 29(5):2909-2919. PubMed ID: 35621627
[TBL] [Abstract] [Full Text] [Related]
9. Ukrainian prospective study in patients with T-cell non-Hodgkin lymphomas.
Kriachok I; Shudrak N; Tytorenko I; Stepanishyna Y; Martynchik A; Aleksik O; Novosad O; Kadnikova T; Pastushenko Y; Kyschevoy E; Shokun N
Exp Oncol; 2021 Dec; 43(4):346-350. PubMed ID: 34967534
[TBL] [Abstract] [Full Text] [Related]
10. Primary Mediastinal B-Cell Lymphoma: A 2021 Update on Genetics, Diagnosis, and Novel Therapeutics.
Ahmed Z; Afridi SS; Shahid Z; Zamani Z; Rehman S; Aiman W; Khan M; Mir MA; Awan FT; Anwer F; Iftikhar R
Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):e865-e875. PubMed ID: 34330673
[TBL] [Abstract] [Full Text] [Related]
11. [Role of Palliative Care in the Introduction of Chemotherapy in Patients with Poor Performance Status].
Sato I; Nakaya N; Obara Y; Kurosaka N; Ueno S; Nakajima H
Gan To Kagaku Ryoho; 2021 May; 48(5):735-737. PubMed ID: 34006726
[TBL] [Abstract] [Full Text] [Related]
12. The prognostic significance of whole-body and spleen MTV (metabolic tumor volume) scanning for patients with diffuse large B cell lymphoma.
Yamanaka S; Miyagawa M; Sugawara Y; Hasebe S; Fujii T; Takeuchi K; Tanaka K; Yakushijin Y
Int J Clin Oncol; 2021 Jan; 26(1):225-232. PubMed ID: 33097970
[TBL] [Abstract] [Full Text] [Related]
13. [Isolated plasmablastic lymphoma of nasal mucosa in an immunocompetent patient achieving complete remission after multimodal treatment: about an African patient and literature review].
Tissir R; Rais H; Tazi I
Pan Afr Med J; 2020; 37():22. PubMed ID: 33062124
[TBL] [Abstract] [Full Text] [Related]
14. Impact of complete surgical resection on outcome in aggressive non-Hodgkin lymphoma treated with immunochemotherapy.
Schmitz C; Rekowski J; Müller SP; Farsijani N; Hertenstein B; Franzius C; von Verschuer U; La Rosée P; Freesmeyer M; Wilop S; Krohn T; Raghavachar A; Ganser A; Bengel FM; Prange-Krex G; Kroschinsky F; Kotzerke J; Giagounidis A; Dührsen U; Hüttmann A
Cancer Med; 2020 Nov; 9(22):8386-8396. PubMed ID: 32926763
[TBL] [Abstract] [Full Text] [Related]
15. Chidamide combined with ibrutinib improved the prognosis of primary bone marrow diffuse large B cell lymphoma.
Tian C; Chen Z; Li Y
J Int Med Res; 2020 Jul; 48(7):300060520936053. PubMed ID: 32643971
[TBL] [Abstract] [Full Text] [Related]
16. [Comparison the efficacy and prognosis of different first-line treatment for elderly diffuse large B-cell lymphoma].
Liu P; Jiang SY; He XH; Qin Y; Gui L; Zhou SY; Yang JL; Yang S; Wen TY; Shi YK
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):234-241. PubMed ID: 32252203
[No Abstract] [Full Text] [Related]
17. How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
Garnache-Ottou F; Vidal C; Biichlé S; Renosi F; Poret E; Pagadoy M; Desmarets M; Roggy A; Seilles E; Soret L; Schillinger F; Puyraimond S; Petrella T; Preudhomme C; Roumier C; MacIntyre EA; Harrivel V; Desbrosses Y; Gruson B; Geneviève F; Thepot S; Drebit Y; Leguay T; Gros FX; Lechevalier N; Saussoy P; Salaun V; Cornet E; Benseddik Z; Veyrat-Masson R; Wagner-Ballon O; Salanoubat C; Maynadié M; Guy J; Caillot D; Jacob MC; Cahn JY; Gressin R; Rose J; Quesnel B; Guerin E; Trimoreau F; Feuillard J; Gourin MP; Plesa A; Baseggio L; Arnoux I; Vey N; Blaise D; Lacroix R; Arnoulet C; Benet B; Dorvaux V; Bret C; Drenou B; Debliquis A; Latger-Cannard V; Bonmati C; Bene MC; Peterlin P; Ticchioni M; Rohrlich PS; Arnaud A; Wickenhauser S; Bardet V; Brechignac S; Papoular B; Raggueneau V; Vargaftig J; Letestu R; Lusina D; Braun T; Foissaud V; Tamburini J; Bennani H; Freynet N; Cordonnier C; Le Garff-Tavernier M; Jacques N; Maloum K; Roos-Weil D; Bouscary D; Asnafi V; Lhermitte L; Suarez F; Lengline E; Féger F; Battipaglia G; Mohty M; Bouyer S; Ghoual O; Dindinaud E; Basle C; Puyade M; Lafon C; Fest T; Roussel M; Cahu X; Bera E; Daliphard S; Jardin F; Campos L; Solly F; Guyotat D; Galoisy AC; Eischen A; Mayeur-Rousse C; Guffroy B; Recher C; Loosveld M; Garnier A; Barlogis V; Rosenthal MA; Brun S; Contentin N; Maury S; Callanan M; Lefebvre C; Maillard N; Okamba P; Ferrand C; Adotevi O; Saas P; Angelot-Delettre F; Binda D; Deconinck E
Blood Adv; 2019 Dec; 3(24):4238-4251. PubMed ID: 31869411
[TBL] [Abstract] [Full Text] [Related]
18. Clinical Effect of CD25 on the prognosis of Diffuse Large B Cell Lymphoma with Secondary Central Nervous System Relapse.
Oka S; Ono K; Nohgawa M
Pathol Oncol Res; 2020 Jul; 26(3):1843-1850. PubMed ID: 31768966
[TBL] [Abstract] [Full Text] [Related]
19. Targeting on glycosylation of mutant FLT3 in acute myeloid leukemia.
Hu X; Chen F
Hematology; 2019 Dec; 24(1):651-660. PubMed ID: 31533545
[No Abstract] [Full Text] [Related]
20. [Prognostic study of 229 follicular lymphoma patients treated with rituximab combined with chemotherapy].
Wang N; Xu PP; Wang L; Cheng S; Zhao WL; Sun HP
Zhonghua Xue Ye Xue Za Zhi; 2019 Jan; 40(1):46-51. PubMed ID: 30704228
[No Abstract] [Full Text] [Related]
[Next]
